MRI‐Based Assessment of Margin Status Determinants, Preoperative Predictors, and Prognostic Outcomes in Breast‐Conserving Surgery Following Neoadjuvant Therapy
World Journal of Surgery · 2025
DOI: 10.1002/wjs.70072 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Surgery, 2025. Verfasst von Xinyu Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Third Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianji…. Hauptthemen laut MEDLINE: Mastectomy, Segmental, Neoadjuvant Therapy, Margins of Excision, Magnetic Resonance Imaging. Die Arbeit nennt 35 Literaturangaben. Gefördert von: The Young Scientists Fund of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Background and Purpose This MRI‐based study investigates factors influencing and predictors of margin status in neoadjuvant therapy followed by patients with breast‐conserving surgery (NAT‐BCS) and evaluates associated locoregional/distant control outcomes. Materials and Methods We conducted a retrospective analysis of 117 consecutive patients with breast cancer (BC) who underwent NAT‐BCS between June 2014 and June 2024. All patients received magnetic resonance imaging (MRI) examinations both before and after NAT.
Results
Univariate analysis identified factors influencing surgical margin status as molecular subtype (with HER2+ showing the lowest positive rate, followed sequentially by triple‐negative breast cancer (TNBC), Luminal B HER2+, Luminal A, and Luminal B HER2‐), nonmass enhancement (NME) on pre‐NAT MRI, axillary lymph node metastasis, post‐NAT MRI shrinkage pattern, postoperative pathological complete response (pCR) status, pN status, and lymphovascular invasion (LVI); however, multivariate analysis demonstrated that only LVI independently affected margin status, and NME on pre‐NAT MRI independently predicted margin status, with 106 patients ultimately undergoing BCS, exhibiting a locoregional recurrence (LRR) rate of 1.9% (2/106) and a distant metastasis (DM) rate of 2.8% (3/106).
Conclusion
The presence of NME on pre‐NAT MRI could be a predictor for margin status, possibly informing surgical strategy formulation. Concurrently, LVI might represent a distinct determinant influencing margin outcomes. NAT‐BCS therapy has achieved favorable local‐regional and distant control outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Third Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
- Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
- Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.
- Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
ORCID-Profile: Xinyu Liu, Shunan Wang
Förderung
- The Young Scientists Fund of the National Natural Science Foundation of China
Zitieren
APA
Liu, X., Liu, Y., Ma, T., Zhang, S., Liu, L., Wang, S., Zhang, Y., Liu, X., & Zhang, J. (2025). MRI‐Based Assessment of Margin Status Determinants, Preoperative Predictors, and Prognostic Outcomes in Breast‐Conserving Surgery Following Neoadjuvant Therapy. World Journal of Surgery. https://doi.org/10.1002/wjs.70072
Vancouver
Liu X, Liu Y, Ma T, Zhang S, Liu L, Wang S, et al. MRI‐Based Assessment of Margin Status Determinants, Preoperative Predictors, and Prognostic Outcomes in Breast‐Conserving Surgery Following Neoadjuvant Therapy. World Journal of Surgery. 2025. doi:10.1002/wjs.70072
BibTeX
@article{Liu2025,
author = {Liu, Xinyu and Liu, Yan and Ma, Tao and Zhang, Shichao and Liu, Lei and Wang, Shunan and Zhang, Yi and Liu, Xu and Zhang, Jin},
title = {MRI‐Based Assessment of Margin Status Determinants, Preoperative Predictors, and Prognostic Outcomes in Breast‐Conserving Surgery Following Neoadjuvant Therapy},
journal = {World Journal of Surgery},
year = {2025},
doi = {10.1002/wjs.70072}
}
EUVIMED